Johnson & Johnson (JNJ)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
170.48+4.50 (+2.71%)
At close: 4:00PM EST
169.60 -0.88 (-0.52%)
Before hours: 8:09AM EST
| Previous close | 165.98 |
| Open | 169.70 |
| Bid | 0.00 x 1100 |
| Ask | 0.00 x 1200 |
| Day's range | 169.39 - 173.65 |
| 52-week range | 109.16 - 173.65 |
| Volume | 13,972,747 |
| Avg. volume | 7,730,140 |
| Market cap | 448.795B |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | 26.81 |
| EPS (TTM) | 6.36 |
| Earnings date | 20 Apr 2021 |
| Forward dividend & yield | 4.04 (2.43%) |
| Ex-dividend date | 22 Feb 2021 |
| 1y target est | 174.06 |
- Editor's pickYahoo Finance
Coronavirus update: J&J to release vaccine data next week; strain from Brazil confirmed in US
Johnson and Johnson expects vaccine data next week.
- Motley Fool
Is Intuitive Surgical a Buy?
Intuitive Surgical is down more than 7% since the start of this year. Does this present a buying opportunity or is it the harbinger of more bad news?
- Motley Fool
Johnson & Johnson Rises on Q4 Beats, Coronavirus Vaccine Hopes
Johnson & Johnson (NYSE: JNJ) delivered an encouraging set of quarterly results on Tuesday, which included a promising -- albeit limited -- update on its coronavirus vaccine candidate. For the sprawling company's fourth quarter of fiscal 2020, revenue came in at just under $22.
© 2021 Verizon Media. All rights reserved.
